Edwards Life Sciences, a leader in the artificial heart valve industry for over 60 years, recently held a heartwarming event in Singapore where patients who received their innovative heart valves shared their life-changing experiences. One notable patient, Choi Hae-hoon, has transformed his health after undergoing a minimally invasive procedure called Transcatheter Aortic Valve Implantation (TAVI) due to severe aortic valve stenosis. This procedure has become crucial as the number of patients with heart valve issues rises, particularly with an aging population. Edwards’ Singapore facility produces over 20,000 valves monthly with a meticulous manual process, and the company emphasizes a patient-centered approach to enhance awareness of heart health and improve the lives of patients globally.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.mk.co.kr/en/it/12134152
